BREAST CANCER;
CARDIOMYOPATHY;
CARDIOVASCULAR MAGNETIC RESONANCE;
CONTRAST ENHANCEMENT;
ECHOCARDIOGRAPHY;
HEART LEFT VENTRICLE FAILURE;
HEART LEFT VENTRICLE WALL;
HUMAN;
LATE GADOLINIUM ENHANCEMENT;
LETTER;
PRIORITY JOURNAL;
ANTIBODIES, MONOCLONAL;
BREAST NEOPLASMS;
ECHOCARDIOGRAPHY, DOPPLER;
FEMALE;
HUMANS;
MAGNETIC RESONANCE IMAGING, CINE;
VENTRICULAR DYSFUNCTION, LEFT;
EID: 82955222870PISSN: 07351097EISSN: 15583597Source Type: Journal DOI: 10.1016/j.jacc.2011.06.071Document Type: Letter
The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor IIpositive breast cancer treated with adjuvant trastuzumab therapy
N. Fallah-Rad, J.R. Walker, and A. Wassef The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor IIpositive breast cancer treated with adjuvant trastuzumab therapy J Am Coll Cardiol 57 2011 2263 2270
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents
W.G. Hundley, D.A. Bluemke, and P.J. Finn ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents J Am Coll Cardiol 55 2010 2614 2662
Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy
N. Fallah-Rad, M. Lytwyn, T. Fang, I. Kirkpatrick, and D.S. Jassal Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy J Cardiovasc Magn Reson 10 2008 5
Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: A retrospective study
D. Wadhwa, N. Fallah-Rad, and D. Grenier Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study Breast Cancer Res Treat 117 2009 357 364
Reversibility of trastuzumab-related cardiotoxicity: New insights based on clinical course and response to medical treatment
DOI 10.1200/JCO.2005.13.300
M.S. Ewer, M.T. Vooletich, and J.B. Durand Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment J Clin Oncol 23 2005 7820 7826 (Pubitemid 46657379)
